Get started
Author

Tori J. Fuller

Observed name: Tori Fuller
ORCID: 0000-0002-5506-260X
Observed ORCID: 0000-0002-5506-260X
OpenAlex ID: A5078750085
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
2018 · Karen L. Bride, Tiffaney L. Vincent, et al. · Blood · 229
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL
2022 · Caroline Diorio, Ryan Murray, et al. · Blood · 132
Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia
2021 · Karen L. Bride, Hai Hu, et al. · Haematologica · 43
PDF
The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2020 · Joanna Pierro, Jason Saliba, et al. · Molecular Cancer Research · 30
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome
2025 · Changya Chen, Jason Xu, et al. · Blood · 17
Abstract 2642: Preclinical efficacy of daratumumab in acute lymphoblastic leukemia
2017 · Karen Lee Bride, Tiffaney Vincent, et al. · Cancer Research · 1
Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies
2026 · Rawan Shraim, Gongping Shi, et al. · Blood
Correction: Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2026 · Haley Newman, Shawn H.R. Lee, et al. · Blood Cancer Discovery
PDF
Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes
2024 · David Teachey, Haley Newman, et al. · Research Square
Supplementary Figures 1-11 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Table 2 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Table 1 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Information from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Table 3 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Table 1 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Table 2 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Table 3 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Supplementary Figures 1-11 from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
PDF
Supplementary Information from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Data from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Data from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia
2023 · Joanna Pierro, Jason Saliba, et al.
Targeting CD38 in T-ALL Upregulates the Targetable Polyamine Metabolism Pathway
2022 · Caroline Diorio, Tiffaney L. Vincent, et al. · Blood
Works count: 22
Citation count: 452
H-index: 5
I10-index: 5
Year
Topic
Type